Richard J. Isaacs
50 Ruahine Street
Palmerston North, MWT 4414, New Zealand
Palmerston North, MWT 4414, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Proton pump inhibition to prevent delayed chemotherapy-induced nausea and vomiting in patients receiving adjuvant or neoadjuvant breast cancer chemotherapy: a phase II, randomised double-blind crossover trial (PantoCIN).
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 29, 2024
A prospective audit on the use of prophylactic antiemetics and rates of CINV in patients receiving carboplatin AUC≥4 or combination anthracycline-cyclophosphamide.
Journal: The New Zealand medical journal
Published: April 30, 2021
Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover.
Journal: Cancers
Published: May 28, 2020
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 30, 2019
Neoadjuvant chemotherapy in non-metastatic breast cancer: a study on practice trends in a regional cancer treatment service.
Journal: Internal medicine journal
Published: January 13, 2019
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 24, 2016
A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer.
Journal: Internal medicine journal
Published: January 05, 2016
Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival.
Journal: Frontiers in oncology
Published: November 02, 2013
A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 07, 2013
Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study.
Journal: BMC cancer
Published: March 05, 2013
Treatment with the PARP-inhibitor PJ34 causes enhanced doxorubicin-mediated cell death in HeLa cells.
Journal: Anti-cancer drugs
Published: February 02, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026